Mannatech (NASDAQ:MTEX – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $0.53 earnings per share for the quarter, FiscalAI reports. The company had revenue of $26.65 million during the quarter. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.
Mannatech Stock Up 20.3%
Shares of MTEX traded up $1.03 during trading hours on Thursday, hitting $6.10. The company had a trading volume of 27,782 shares, compared to its average volume of 21,909. The stock’s 50 day moving average price is $5.07 and its 200 day moving average price is $5.74. Mannatech has a 52-week low of $3.80 and a 52-week high of $12.45. The firm has a market cap of $11.77 million, a P/E ratio of -0.91 and a beta of 0.73.
Insider Activity
In other news, Director Kevin Andrew Robbins purchased 7,100 shares of the company’s stock in a transaction on Tuesday, May 19th. The stock was acquired at an average price of $4.17 per share, with a total value of $29,607.00. Following the transaction, the director directly owned 33,333 shares of the company’s stock, valued at approximately $138,998.61. This represents a 27.07% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders have purchased a total of 14,903 shares of company stock valued at $62,155 in the last quarter. 47.50% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In
View Our Latest Stock Report on MTEX
Mannatech Company Profile
Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.
The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.
Read More
- Five stocks we like better than Mannatech
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
- Ryman Checks Into a $1.38B Hospitality Upgrade
- Axos Financial Keeps Proving the Digital Banking Model Works
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
